Effect of rice bran and soybean fermented by Bacillus spp. on lipid profiles of liver, serum, and feces in rats fed high fat diet

Journal of Applied Biological Chemistry

Volumn 54, Issue 2, 2011, Pages 237-242

  Lim, Seong Il ^a   Seong, Ki Seung ^a   Song, Sun Mi ^a   Hwang, Jin Taek ^a   Lee, Boo Yong ^b  

^a Korea Food Research Institute   (South Korea)

^b CHA University   (South Korea)

Author keywords

Bacillus; Fatty liver; Solid fermented material; Triglyceride

Indexed keywords

GLYCINE MAX; RATTUS;

EID: 79956055521     PISSN: 19760442     EISSN: None     Source Type: Journal    
DOI: 10.3839/jksabc.2011.038     Document Type: Article

References (27)

1. Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, and Anthony MS (2004) Dietary soy β-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 134, 511-516.
2. Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, Seto A, and Yano K (2001) Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki. Hypertens Res 24, 337-343.
3. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346, 1221-1231.
4. Angulo P and Lindor KD (2001) Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 21, 81-88.
5. Bayard M, Holt J, and Boroughs E (2006) Nonalcoholic fatty liver disease. Am Fam Physician 73, 1961-1968.
6. Cheik NC, Rossi EA, Guerra RLF, Tenorio NM, do Nascimento CMO, Viana FP, Manzoni MSJ, Carlos IZ, da Silva PL, Vendramini RC, and Damaso AR (2008) Effect of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats. Lipids Health Dis 7, 50-58.
7. Cicero AFG and Gaddi A (2001) Rice bran oil and γ-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 14, 277-289.
8. Fukui K, Tachibana N, Fukuda Y, Takamatsu K, and Sugano M (2004) Ethanol washing does not attenuate the hypocholesterolemic potential of soy protein. Nutrition 20, 984-990.
9. Jariwalla RJ (2001) Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine. Drug Exp Clin Res 27, 17-26.
10. Jo WS, Nam BH, Oh SJ, Choi YJ, Kang EY, Hong SH, Lee SH, and Jeong MH (2008) Hepatic protective effect and single-dose toxicity study of water extract of cordyceps militaris grown upon protaetia dreujtarsis. Korean J Food Sci 40, 106-110.
11. Kerckhoffs DAJM, Brouns F, Hornstra G, and Mensink RP (2002) Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 132, 2494-2505.
12. Leaverton PE (1987) Representative of the Framingham risk model for coronary heart mortality: a comparison with a national cohort study. J Chronic Dis 40, 775-84.
13. Lichtenstein AH, Jalbrt SM, Adlercreutz HZ, Goldin BR, Rasmussen EJ, and Schaefer EJ (2002) Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscl Throm Vas 22, 1852-1858.
14. Lieber CS (1994) Alcohol and the liver. Gastroenterology 106, 1085-1105.
15. Lien TF, Hsu YL, Lo DY, and Chiou RYY (2009) Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats. Nutr Metab 6, 15-21.
16. Lim SI and Lee BY (2010) Anti-diabetic effect of material fermented using rice bran and soybean as the main ingredient by Bacillus sp. J Korean Soc Appl Bio Chem 53, 222-229.
17. Matsumoto K, Watanabe Y, and Yokoyama S (2007) Okara, soybean residue, prevents obesity in a diet-induced murine obesity model. Biosci Biotechnol Biochem 71, 720-727.
18. Nakamoto K, Takayama F, Mankura M, Hidaka Y, Egashira T, Ogino T, Kawaaki H, and Mori A (2009) Beneficial effects of fermented green tea extract in a rat model of nonalcoholic steatohepatitis. J Clin Biochem Nutr 44, 239-246.
19. Oh RC and Lanier JB (2007) Management of hypertriglyceridemia. Am Fam Physician 75, 1365-1371.
20. Park SH, Kim YH, Chon JW, Song YJ, and Han JH (2005) Study of Crataegi fructus for medicinal foods applications -Functional evaluation of fermented liquid on the lipid profile improvement high fat diet. Kor J Ori Physiol Pathol 19, 1272-1280.
21. Reddy JK and Sambasiva Rao M (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastr L 290, 852-858.
22. Refstie S, Storebakken T, and Roem AJ (1998) Feed consumption and conversion in Atlantic salmon (Salmo salar) fed diets with fish meal, extracted soybean meal or soybean meal with reduced content of oligosaccharides, trypsin inhibitors, lectins and soya antigens. Aquaculture 162, 301-312.
23. Revilla E, Maria CS, Miramontes E, Bautista J, Garcia-Martinez A, Cremades O, Cret R, and Parrado J (2009) Nutraceutical composition, antioxidant activity and hypocholesterolemic effect of a water-soluble enzymatic extract from rice bran. Food Res Int 42, 387-393.
24. Rossi EA, Cavallini DCU, Carlos IZ, Vendramini RC, Damaso AR, and de Valdez GF (2008) Intake of isoflavonesupplemented soy yogurt fermented with Enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats. Eur Food Res Technol 228, 275-282.
25. Sohn ES (1975) A study on hyperlipidemia in normal and hypertensive Korean (I). J Korean Med Assoc 18, 345-354.
26. Yang CM, Lee JI, Kim SJ, Song BS, Lee DH, Park SC, and Sohn ES (1980) A clinical study on the phenotype of hyperlipoproteinemia in various diseases in Korea. J Korean Med Assoc 23, 151-159.
27. Zhuo XG, Melby MK, and Watanabe S (2004) Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans, J Nutr 134, 2395-2400.